Scientists at the Emory Institute for Drug Discovery will partner with GlaxoSmithKline (GSK) and Alnylam Pharmaceuticals on research aimed at developing new drugs for neglected tropical diseases in least developed countries.
Emory University has signed a Memorandum of Understanding with GSK as the first university to join GSK's new "intellectual property pool," consisting of hundreds of patents and patent applications, scientific reports and analysis. Under the MOU, Emory will have access to GSK scientists who can provide information about the history and current development of selected compounds targeted to the neglected diseases.
Read more at: http://shared.web.emory.edu/emory/news/releases/2010/01/emory-will-partner-with-glaxosmithkline-on-drug-research.html
Monday, January 25, 2010
Friday, January 15, 2010
Fort McPherson’s biotech makeover moves forward
A proposed 170-acre research park, expected to be the engine of a redeveloped Fort McPherson, could generate up to 7,000 jobs and lure Big Pharma to southwest Atlanta.
Read more: http://www.bizjournals.com/atlanta/stories/2010/01/18/story1.html?b=1263790800%5E2726281
Read more: http://www.bizjournals.com/atlanta/stories/2010/01/18/story1.html?b=1263790800%5E2726281
Sciele Pharma, Inc., a Shionogi Group Company, Announces Name Change
Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) today announced that its U.S.-based group company, Sciele Pharma, Inc. (hereafter “Sciele”), and two group companies have changed their company names as detailed below.
1. New Company Name (old company names are shown in parentheses)
(1) Shionogi Pharma, Inc. (Sciele Pharma, Inc.)
(2) Shionogi Pharma Sales, Inc. (Sciele Pharma Sales, Inc.)
(3) Shionogi Ireland Ltd. (Sciele Pharma Ireland Ltd.)
Read More: http://www.gabio.org/pr_details.aspx?subid=285&refid=8
1. New Company Name (old company names are shown in parentheses)
(1) Shionogi Pharma, Inc. (Sciele Pharma, Inc.)
(2) Shionogi Pharma Sales, Inc. (Sciele Pharma Sales, Inc.)
(3) Shionogi Ireland Ltd. (Sciele Pharma Ireland Ltd.)
Read More: http://www.gabio.org/pr_details.aspx?subid=285&refid=8
Wednesday, January 13, 2010
IBB Recognized in National Academies Report/Video
Parker H. Petit Institute for Bioengineering and Bioscience (IBB) Recognized in National Academies
Following the release of a report entitled, “A New Biology for the 21st Century,” by the National Academies on the future of biological science, three of the study's authors discuss the key findings on video. This report identified how biology can help meet challenges like feeding a growing population, providing adequate health care, generating energy to meet increasing demands, and coping with global climate change.
In this video, Dr. Phillip Sharp (IBB Distinguished Lecturer in 2009), Dr. Anthony Janetos, and Dr. Keith Yamamoto explain the study's goals and conclusions.
On page 64 of the report, IBB was cited as one of two examples in the country that has successfully recognized the “limitation of traditional departmental structures for establishing the New Biology, and have responded not by eliminating departmental structures, but rather by supplementing or overlaying them with interdisciplinary programs and institutes that have both research and educational objectives.”
View the video here: http://www.youtube.com/watch?v=hasV1f7HdB4
Following the release of a report entitled, “A New Biology for the 21st Century,” by the National Academies on the future of biological science, three of the study's authors discuss the key findings on video. This report identified how biology can help meet challenges like feeding a growing population, providing adequate health care, generating energy to meet increasing demands, and coping with global climate change.
In this video, Dr. Phillip Sharp (IBB Distinguished Lecturer in 2009), Dr. Anthony Janetos, and Dr. Keith Yamamoto explain the study's goals and conclusions.
On page 64 of the report, IBB was cited as one of two examples in the country that has successfully recognized the “limitation of traditional departmental structures for establishing the New Biology, and have responded not by eliminating departmental structures, but rather by supplementing or overlaying them with interdisciplinary programs and institutes that have both research and educational objectives.”
View the video here: http://www.youtube.com/watch?v=hasV1f7HdB4
IBB Recognized in National Academies report/video
Following the release of a report entitled, “A New Biology for the 21st Century,” by the National Academies on the future of biological science, three of the study's authors discuss the key findings on video. This report identified how biology can help meet challenges like feeding a growing population, providing adequate health care, generating energy to meet increasing demands, and coping with global climate change.
In this video, Dr. Phillip Sharp (IBB Distinguished Lecturer in 2009), Dr. Anthony Janetos, and Dr. Keith Yamamoto explain the study's goals and conclusions.
In this video, Dr. Phillip Sharp (IBB Distinguished Lecturer in 2009), Dr. Anthony Janetos, and Dr. Keith Yamamoto explain the study's goals and conclusions.
Subscribe to:
Posts (Atom)
Posts
